Equities

Mevis Medical Solutions AG

Mevis Medical Solutions AG

Actions
TechnologyTechnology
  • Price (EUR)25.60
  • Today's Change0.20 / 0.79%
  • Shares traded0.00
  • 1 Year change-22.42%
  • Beta0.1085
Data delayed at least 15 minutes, as of Apr 23 2024 16:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mevis Medical Solutions AG is a Germany-based provider of software and services for the medical image processing industry, and offers computer support for image-based medical diagnosis and therapy. The Company develops medical application software for industrial customers including turnkey applications, and also research laboratories. In addition to that, the Company operates an online academy and trains professionals, such as radiologists, in working with its products. The Company's software applications support various applicable imaging modalities, especially magnetic resonance tomography (MRT) and digital mammography, but also computer tomography (CT), tomosynthesis and digital sonography based on ultrasonics.

  • Revenue in EUR (TTM)17.34m
  • Net income in EUR4.92m
  • Incorporated2006
  • Employees101.00
  • Location
    Mevis Medical Solutions AGCaroline-Herschel-Str. 1BREMEN 28359GermanyDEU
  • Phone+49 421224950
  • Fax+49 42 122495999
  • Websitehttps://www.mevis.de/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Intershop Communications AG37.99m-3.08m28.58m299.00--2.5188.760.7524-0.2156-0.21562.620.77960.9582--8.65127,046.80-7.77-7.02-11.70-10.3341.6042.98-8.11-6.71---5.310.5237--3.224.0213.35---21.81--
Francotyp Postalia Holding AG244.68m3.91m40.75m1.05k10.351.471.790.16660.24160.241615.331.701.355.5210.76233,692.502.16-0.77456.91-1.5055.4155.101.60-0.63790.6782--0.572--23.203.991,416.163.55-8.29--
NAGA Group AG47.84m-19.64m43.78m173.00--0.34911.270.9151-0.3601-0.36010.86672.320.3151--6.75276,526.00-12.97-10.18-14.55-11.10106.86108.28-41.16-41.43--0.17250.0021--8.9335.00-266.14--62.99--
MeVis Medical Solutions AG17.34m4.92m46.23m101.009.402.599.222.672.702.709.539.790.5853--5.21171,702.5016.6022.7423.0229.8597.4396.9028.3735.45----0.0027.86-7.57-0.4922-36.84-8.38-17.460.00
Cyan AG8.21m-21.45m50.88m124.00--0.7778--6.20-1.32-1.320.49373.240.100131.111.1160,330.88-26.16-8.56-28.41-9.8231.5578.30-261.43-48.261.92-17.150.057--0.6366---18.90------
YOC AG28.13m1.73m53.89m87.0030.0328.8817.571.920.51620.51628.150.53682.70--5.83390,713.5016.6312.6676.16--47.5344.186.155.55--43.520.36730.0024.4110.2726.14--19.61--
Exasol AG34.84m-14.44m66.94m220.00--138.76--1.92-0.6057-0.60571.460.01791.3291.7426.48158,346.80-54.73---58.15--92.28---41.45--23.82--0.00--20.87--48.75------
Data as of Apr 23 2024. Currency figures normalised to Mevis Medical Solutions AG's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.